Newbridge Financial Services Group, Inc. - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 369 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
0
-100.0%
0.00%
Q2 2023$856
+9.3%
210.0%0.00%
Q1 2023$783
+6.8%
210.0%0.00%
Q4 2022$733
-26.7%
210.0%0.00%
-100.0%
Q3 2022$1,000
-66.7%
21
-63.2%
0.00%
-50.0%
Q2 2022$3,000
-94.6%
57
-92.7%
0.00%
-92.9%
Q1 2022$56,000
-8.2%
776
+49.2%
0.03%
-3.4%
Q4 2021$61,000
+1120.0%
520
+1344.4%
0.03%
+866.7%
Q3 2021$5,000
-50.0%
36
-40.0%
0.00%
-50.0%
Q2 2021$10,000
+100.0%
600.0%0.01%
+50.0%
Q1 2021$5,000600.00%
Q3 2020$000.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders